Danaher (DHR)
Company | Ticker | Sector | Industry | Quality | PAR |
---|---|---|---|---|
Danaher | DHR | Healthcare | Diagnostics & Research | 87 | 4.5% |
Current Price ( 4/25 4:00PM EDT) | $245.80 | |||
CAPS Rating (Rate this stock on CAPS) | ||||
Expected Income Statement | ||||
Current Sales | 23,890.0 | |||
Sales Growth Forecast | 4.5% | |||
Net Profit Margin | 27.2% | |||
Projected Shares Outstanding | 735.17 | |||
EPS - Five year Forecast | $11.03 | |||
Average P/E Ratio | 27.0 | |||
Projected Average Price | $297.75 | |||
Price Appreciation (Annualized) | 3.9% | |||
Annual Dividend Yield | 0.6% | |||
Projected Annual Return | 4.5% | |||
Quality | ||||
Financial Strength | 97 | 24.2 | ||
EPS Stability | 78 | 19.4 | ||
Industry Sales Growth Rate | 9.5% | 6.0 | ||
Industry Net Profit Margin | 17.5% | 19.4 | ||
Calculated Quality Rating | 69.0 | |||
Fool CAPS | ||||
Total Players
599
Outperforms
25
Underperforms
All-Stars (111)
107
Outperforms (96%)
4
Underperforms
|
||||
Fundamental Data Updated: 04/05/2024 |